Praill Anthony Scott Insider Trades

Insider Trading History

Track insider trading activity for Praill Anthony Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $59.7k 277,273 shares
Last Trade
Aug 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8M 240,087 shares
$307.47
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $8.01k 37,186 shares
Last Trade
Dec 08, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$35.7M 28,700 shares
$1,242.85
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.83k 8,486 shares
Last Trade
Apr 29, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.25M 938 shares
$2,397.50
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.63k 7,548 shares
Last Trade
Apr 29, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$19.2k 8 shares
$2,397.50
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Apr 29, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$8.99M 3,750 shares
$2,397.50
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.62k 7,540 shares
Last Trade
Mar 31, 2021 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$67k 22 shares
$3,045.00
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.62k 7,518 shares
Last Trade
Dec 31, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$49.3k 22 shares
$2,240.00
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.61k 7,496 shares
Last Trade
Sep 30, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$53.9k 22 shares
$2,450.00
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $131k 606,557 shares
Last Trade
Sep 15, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.8B 606,557 shares
$2,975.00
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.61k 7,474 shares
Last Trade
Jun 30, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$26.5k 22 shares
$1,203.65
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $23.3k 108,366 shares
Last Trade
Jun 26, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$70.5M 57,170 shares
$1,233.75
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.61k 7,452 shares
Last Trade
Mar 31, 2020 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$15.3k 22 shares
$696.92
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.6k 7,430 shares
Last Trade
Dec 31, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$26.6k 22 shares
$1,206.97
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.6k 7,408 shares
Last Trade
Sep 30, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$21.3k 22 shares
$967.57
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $12.3k 57,170 shares
Last Trade
Sep 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116M 108,366 shares
$1,067.67
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $1.59k 7,386 shares
Last Trade
Jun 28, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$49.7k 22 shares
$2,257.50
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $15.9k 73,632 shares
Last Trade
Mar 29, 2019 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.81M 211 shares
$8,574.99
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $15.8k 73,421 shares
Last Trade
Dec 31, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$1.26M 211 shares
$5,983.25
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $21.5k 100,000 shares
Last Trade
Nov 08, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.07B 100,000 shares
$10,673.24
$0.22
Kintara Therapeutics
Kintara Therapeutics KTRA
Chief Financial Officer
Holding Value $15.8k 73,210 shares
Last Trade
Sep 28, 2018 Purchase (Other)Another type of insider transaction reported on SEC Form 4.
$2.69M 211 shares
$12,731.24
$0.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up